  Check back regularly or bookmark this page for all the latest news from Acceleris. Liverpool Needs a Unified Business Front RedX Pharma Win North West Newcomer of the Year At an exclusive lunch at the Midland Hotel in Manchester, winners were announced in six categories, ranging from North West Newcomer - the most exciting new business, to North West Ambassador - the award for outstanding contribution by a senior business leader. The awards, supported by headline sponsor Jaguar, were made after readers voted on a shortlist compiled by a high-level panel of judges. Liverpool-based bio-medical start-up RedX Pharma was named North West Newcomer, ahead of fledgling tea brand Charbrew and sweet business Goody Good Stuff. Judges were swayed by RedX's ambitious growth plans, which with the help of more than £5m from the Regional Growth Fund, will create more than 100 high-value scientific jobs in Liverpool at a cancer research base. Finance director Norman Molyneux was presented with the award by sponsor Odgers Interim, represented by consultant Alex Lenihan. Chris Barry North West Editor of TheBusinessDesk.com said: "In challenging economic conditions our winners and finalists have set a fantastic example to the North West business community. We congratulate the winners and thank our sponsors for their support in helping us to celebrate business in the North West." The judges for the awards were: Robert Hough chairman of the NWDA; John Young, North West Agent at the Bank of England, entrepreneur Richard O'Sullivan, Damian Waters from CBI North West, non-executive director and former PwC senior partner David McKeith, and JourneyUK MD Laura Wolfe - one of the winners last year. Redx Oncology, a spin-out of Liverpool drug discovery company Redx
Pharma, has been launched. Budget Announcement relating to the Government's Venture Capital Schemes Q&A Venture Capital - How can the recent changes to the EIS rules benefit private investors? Redx Pharma Ltd wins 'Start-Up of the Year' Award at 2011 Bionow Annual Awards Ceremony Green light for new Redx cancer drug research unit Acceleris launches maiden EIS fund George Osborne plans £100m tax break to help fast-growing small firms Acceleris form a strategic alliance with Seneca Acceleris Investee Company Memsstar ranked in Sunday Times Tech Track 100 list. Click here to follow us on
If you would like to register an interest in any of our current investment opportunities please complete the online form below.
|
|
Acceleris is Authorised and Regulated by the Financial Services Authority